BioPharma

The report, which covers the 2021-22 year, found that complaints to the Ombudsman decreased by 22.7 per cent, "continuing a trend from the previous year."

Medibank has announced a joint venture with mental health provider Aurora Healthcare under which they will deliver an integrated care model.

The company said it developed the 'Stretch RAP in consultation with its internal working group, First Nations Employee Network and external First Nations advisors.

Monash University has announced a new partnership with Sheba Medical Centre which is based in the Israel city of Tel Aviv.

Australian company Clinuvel has initiated its second stroke trial with the first patient administered its new PRÉNUMBRA Instant (afamelanotide) formulation.

Sister2sister vice chair Alecia Wood and welfare manager Linda Beuzeville visited Organon on International Women's Day and spoke about the importance of supporting girls as they develop their sense of place in society.

With this program, we can help Australia’s world-class medical research and biotech community to be at the forefront of contributions to unlocking the potential of mRNA science," said Moderna general manager Michael Azrak.

Does anyone else have the impression that PBS decision-making is suffering from a dangerous lack of political and policy interest?

Contributions can still be made to the 2023 'Kosi Challenge' but MSD has taken this year's 'Pharma Cup' while an industry executive has also raised the single largest amount by an individual.

Stuart Arbuckle is the executive vice president and chief operating officer of Vertex. He spoke with BioPharmaDispatch during a trip to Australia last week.

A change in the membership of the federal government's HTA review reference committee. What does it say about the review and what does it mean? Still waiting for final outcomes ahead of the 1 April price changes and a question from the audience about what patients can do to ensure their voices are heard.

Taken at face value, it means that the minister's own officials did not communicate the company's intention to remove these medicines from the PBS as a result of the catch-up reduction.